These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 22799022)
1. [Research progress of liver X receptor agonists]. Liang Y; Guo CB; Zhang C; Hou ZG Yao Xue Xue Bao; 2012 Apr; 47(4):427-33. PubMed ID: 22799022 [TBL] [Abstract][Full Text] [Related]
2. Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta. Hu B; Unwalla R; Collini M; Quinet E; Feingold I; Goos-Nilsson A; Wihelmsson A; Nambi P; Wrobel J Bioorg Med Chem; 2009 May; 17(10):3519-27. PubMed ID: 19394832 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro. Padovani AM; Molina MF; Mann KK Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114 [TBL] [Abstract][Full Text] [Related]
8. Hepatic TRAP80 selectively regulates lipogenic activity of liver X receptor. Kim GH; Oh GS; Yoon J; Lee GG; Lee KU; Kim SW J Clin Invest; 2015 Jan; 125(1):183-93. PubMed ID: 25437875 [TBL] [Abstract][Full Text] [Related]
9. Atherosclerosis: lessons from LXR and the intestine. Bonamassa B; Moschetta A Trends Endocrinol Metab; 2013 Mar; 24(3):120-8. PubMed ID: 23158108 [TBL] [Abstract][Full Text] [Related]
10. Biological role of liver X receptors. Baranowski M J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656 [TBL] [Abstract][Full Text] [Related]
11. Liver X receptors as potential therapeutic targets in atherosclerosis. Zhu Y; Li Y Clin Invest Med; 2009 Oct; 32(5):E383-94. PubMed ID: 19796580 [TBL] [Abstract][Full Text] [Related]
12. The Hexane Fraction of cyperus rotundus Prevents Non-Alcoholic Fatty Liver Disease Through the Inhibition of Liver X Receptor α-Mediated Activation of Sterol Regulatory Element Binding Protein-1c. Oh GS; Yoon J; Lee GG; Kwak JH; Kim SW Am J Chin Med; 2015; 43(3):477-94. PubMed ID: 25967664 [TBL] [Abstract][Full Text] [Related]
13. Liver X receptor activation promotes polyunsaturated fatty acid synthesis in macrophages: relevance in the context of atherosclerosis. Varin A; Thomas C; Ishibashi M; Ménégaut L; Gautier T; Trousson A; Bergas V; de Barros JP; Narce M; Lobaccaro JM; Lagrost L; Masson D Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1357-65. PubMed ID: 25838428 [TBL] [Abstract][Full Text] [Related]
14. Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis. Lund EG; Menke JG; Sparrow CP Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1169-77. PubMed ID: 12615685 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent. Larrede S; Quinn CM; Jessup W; Frisdal E; Olivier M; Hsieh V; Kim MJ; Van Eck M; Couvert P; Carrie A; Giral P; Chapman MJ; Guerin M; Le Goff W Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1930-6. PubMed ID: 19729607 [TBL] [Abstract][Full Text] [Related]
17. Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis. Hu B; Collini M; Unwalla R; Miller C; Singhaus R; Quinet E; Savio D; Halpern A; Basso M; Keith J; Clerin V; Chen L; Resmini C; Liu QY; Feingold I; Huselton C; Azam F; Farnegardh M; Enroth C; Bonn T; Goos-Nilsson A; Wilhelmsson A; Nambi P; Wrobel J J Med Chem; 2006 Oct; 49(21):6151-4. PubMed ID: 17034119 [TBL] [Abstract][Full Text] [Related]
18. Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP. Zanotti I; Potì F; Favari E; Steffensen KR; Gustafsson JA; Bernini F J Pharmacol Exp Ther; 2006 Apr; 317(1):395-401. PubMed ID: 16415093 [TBL] [Abstract][Full Text] [Related]
19. Taurine is a liver X receptor-α ligand and activates transcription of key genes in the reverse cholesterol transport without inducing hepatic lipogenesis. Hoang MH; Jia Y; Jun HJ; Lee JH; Hwang KY; Choi DW; Um SJ; Lee BY; You SG; Lee SJ Mol Nutr Food Res; 2012 Jun; 56(6):900-11. PubMed ID: 22707265 [TBL] [Abstract][Full Text] [Related]
20. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype. Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]